Эта страница была автоматически переведена ИИ с английского оригинала. Некоторые формулировки могут быть неточными. Посмотреть на английском

French health authorities have confirmed the world's first documented human infection with Shamonda virus, a virus previously identified in animals. The patient, who was severely immunocompromised, died in early October 2026. Authorities emphasize that no risk to the general public has been identified based on current evidence.
French health authorities have confirmed the world's first documented human infection with Shamonda virus, a virus previously identified in animals. The patient, who was severely immunocompromised, died in early October 2026. Authorities emphasize that no risk to the general public has been identified based on current evidence.
France has reported the first officially documented case of Shamonda virus infection in a human, marking a significant development in the surveillance of emerging infectious diseases.
The French Ministry of Health announced the case on October 22, 2026, involving a severely immunocompromised patient receiving treatment for a serious medical condition at Hospices Civils de Lyon.
The patient died in early October. Investigations are ongoing to determine how the infection occurred and whether the virus caused or contributed to the patient's death.
Shamonda virus is an Orthobunyavirus belonging to the Peribunyaviridae family. It was first identified in Nigeria during the mid-1960s.
The virus primarily affects animals, particularly cattle, and is transmitted through bites from small blood-feeding insects known as Culicoides biting midges.
Over the past several decades, Shamonda virus has been detected sporadically in livestock across West, East and Southern Africa, as well as Japan.
In summer 2026, the virus was also identified in European livestock, including cattle in France.
Until the recent French case, no human infection had been officially documented.
According to French public health authorities, the patient had a severely weakened immune system and was receiving treatment for a serious neurological condition.
Laboratory investigations detected Shamonda virus in multiple biological samples, confirming the infection.
Preliminary findings suggest that neurological complications observed before the patient's death were likely associated with the virus.
However, further clinical and laboratory investigations are necessary to clarify the virus's contribution to the patient's condition and death.
Health officials believe the infection may have resulted from the bite of an infected Culicoides midge in eastern France, where the virus had been circulating among animals.
This possible route of transmission has not yet been conclusively established.
French authorities have emphasized that the case is highly unusual because the patient was severely immunocompromised.
Based on currently available information:
This is the first documented human infection with Shamonda virus.
No human-to-human transmission has been identified.
No health risk to the general population has been identified.
The suspected transmission route remains under investigation.
Additional research is needed to understand the virus's potential effects on human health.
The European Centre for Disease Prevention and Control (ECDC) is monitoring the situation in cooperation with French health authorities.
French health officials have notified the World Health Organization (WHO) and the European Centre for Disease Prevention and Control (ECDC).
Clinical, biological and epidemiological investigations are continuing under a One Health approach, which recognizes the connections between human health, animal health and environmental conditions.
The investigation aims to better understand how the infection occurred, identify potential exposure pathways and assess any implications for public health.
The first documented human case of Shamonda virus highlights the importance of continued surveillance of infectious diseases that primarily circulate among animals.
Although current evidence does not indicate a broader public health threat, the case demonstrates why cooperation among medical professionals, veterinary experts and public health authorities remains essential.
French and European health authorities continue to monitor the situation, with further findings expected to improve scientific understanding of Shamonda virus and its potential implications for human health.
Sources: Xinhua Thai News
Статьи в этой категории написаны нашей редакцией, чтобы информировать вас о последних новостях здравоохранения и медицинского туризма.